Febbo Phillip G., Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 8,349 shares on October 6, 2025, at an average price of $36.02, realizing proceeds of about ~$300,709.27. After the transaction, he now holds 92,441 direct shares and has no indirect holdings reported. For retail traders, this is a neutral event: 10b5-1 pre-arranged sale, modest relative to holdings.
Decide: Neutral
Neutral. The filing shows a single insider sale executed under a 10b5-1 plan (transaction code S), with the insider retaining the bulk of holdings; this looks like pre-planned liquidity rather than a discretionary, negative signal. Data completeness is good for this transaction, but cluster activity cannot be determined from this filing alone.
This transaction looks like routine, pre-arranged profit-taking rather than a clear bearish signal. For retail traders, itβs likely noise β not a tradeable event unless corroborated by significant sales from multiple senior insiders or the CEO/CFO.